$PAYX

Schrader Robert L. sold $299K of PAYX

Schrader Robert L. (Sr. VP, CFO) sold 2,600 shares of PAYCHEX INC (PAYX) at $115.09 ($0.30M total) on 2026-07-20.

Original reporting
SEC EDGAR · Schrader Robert L.
Published Jul 21, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 8:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PAYX
Neutral
medium confidence
Mentioned
$PAYX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PAYXNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 2,600 shares at $115.09 on 2026-07-20, totaling $299,234, with holdings after the trade of 18,547 shares.

02

Market read

Traders may monitor insider activity for sentiment, but this disclosure alone does not change PAYCHEX’s fundamentals.

03

What to watch

The article provides only the sale details; it does not state motivations, other concurrent transactions, or whether the CFO’s remaining holdings reflect broader compensation patterns.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-21 after-hours, reflecting the 2026-07-20 sale.

Background

This is an SEC Form 4 insider transaction disclosure for PAYCHEX, reported by the company’s CFO.

Company-level read

Ticker impact

$PAYXNeutralMedium confidence
Context

PAYCHEX CFO Robert L. Schrader sold 2,600 shares in an open-market transaction on 2026-07-20 for about $299K.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal from this single Form 4.

Evidence & confidence

The filing is a disclosed insider sale with specified price and share count, but it does not include new company fundamentals, guidance, or material corporate events.

Market effects

Minimal read-through to the broader sector; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales are often planned for diversification, taxes, or liquidity needs, so the absence of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • PAYCHEX INC

    Subject of the Form 4 insider transaction disclosure.

  • Schrader Robert L.

    PAYCHEX Sr. VP, CFO who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PAYXHighAI 8/10

Paychex (PAYX): The Segment Mix Shift Caught the Street Off Guard, But Guidance Did Not Move

Paychex (PAYX) reported Q1 FY2027 revenue of $1.6B (+6%) and adjusted EPS of $1.34 (+10%), beating estimates. PEO and Insurance Solutions revenue surged 12%, leading to raised full-year PEO guidance. Despite this, the stock sold off, prompting JPMorgan to upgrade to Neutral and raise its price target to $115. Analysts remain divided on the company's segment mix shift and future growth prospects.

$PAYXHighAI 9/10

Paychex Reports $1.63 Billion In Q1 Revenue As Net Income Increases 12% To $429.7 Million

Paychex reported Q1 2027 revenue of $1.63B, up 6% YoY, with net income rising 12% to $429.7M. Growth was driven by payroll, human capital management, and PEO businesses. Operating income increased 14% to $619.2M, while operating margin improved to 38%. The company also reported higher interest income and reduced acquisition-related expenses. Paychex declared $423.6M in dividends and has a $1B share repurchase program.

$PAYXMedAI 8/10

Paychex (PAYX) Beats EPS Estimates, But Slow Growth Weighs on Shares

Paychex (PAYX) reported fiscal Q1 2027 revenue of $1.6B (+6% YoY) and adjusted EPS of $1.34 (+10% YoY), beating estimates. Operating income rose 14% to $619.2M. The company raised guidance for PEO and Insurance Solutions revenue growth to 7-8%. However, total revenue growth outlook remains at 5-6%, and Management Solutions revenue grew just 4%. Shares fell due to slower growth concerns.